Calciphylaxis in Patients With Preserved Kidney Function

Natallia Maroz1, Samer Mohandes2, Halle Field3

  • 1Renal Physicians Inc., Dayton, OH, USA ; Department of Medicine, Wright State University, Boonshoft School of Medicine, Dayton, OH, USA.

Insights

Calcific uremic arteriolopathy (CUA), or calciphylaxis, causes painful wounds in dialysis patients. This study explores non-uremic calciphylaxis (NUC) management and outcomes in patients without kidney disease.

Area of Science:

  • Nephrology
  • Dermatology
  • Vascular Medicine

Background:

  • Calcific uremic arteriolopathy (CUA), also known as calciphylaxis, is a severe condition affecting end-stage renal disease patients.
  • CUA presents as painful, symmetrical wounds that are challenging to treat.
  • Non-uremic calciphylaxis (NUC) occurs in patients without kidney disease, but its management and outcomes are poorly understood.

Purpose of the Study:

  • To describe clinical scenarios of non-uremic calciphylaxis (NUC).
  • To report on therapeutic interventions for wound management in NUC.
  • To contribute to the evidence base for effective NUC treatment strategies.

Main Methods:

  • Case series describing three patients diagnosed with NUC.
  • Detailed reporting of wound management interventions.
  • Documentation of both successful and unsuccessful therapeutic outcomes.

Main Results:

  • Three distinct clinical cases of NUC were presented.
  • Various wound management strategies were applied.
  • The effectiveness and limitations of different interventions were observed.

Conclusions:

  • NUC can occur in patients without significant kidney pathology.
  • Documenting therapeutic interventions in NUC is crucial.
  • Further research is needed to establish optimal NUC management protocols.

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
630
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
588
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
960
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
490
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
313
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
480